EU medtech reform machinations: scrutiny and premarket approval disappear but big role for EMA in proposed compromise
This article was originally published in SRA
Executive Summary
The proposal for a centralized and decentralized pharmaceutical-style pre-market approval system for high-risk and innovative medical devices has disappeared from the latest set of proposals for a new Medical Device Regulation at the European Parliament.